New Development of CAR T-Cell Product Therapies

A recent partnership between Blubird Bio and TC BioPharm has been formed with the intent of developing Gamma Delta CAR T-Cell product therapies for cancer treatment. The agreement was put into place to expand TC BioPharm’s existing Gamma Delta CAR T-Cell program through clinical trials. “Emerging research suggests that gamma delta T cells may constitute […]